Vaccines
Turning back the immunological clock
7 Apr 2021The discovery of how aging impacts memory T cells may unlock novel therapeutic targets to boost immune protection in older adults.
How the flu virus hops from one host to another
29 Nov 2019A*STAR researchers have identified specific sites in the surface protein of influenza viruses that allow the pathogen to adapt to different host organisms.
How to maim a virus without killing it
7 Nov 2019Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.
Targeting TRIM21 for stronger, safer vaccines
16 Oct 2019A*STAR scientists have found a way to strengthen the immune response to adenovirus infection using engineered antibodies.
Unraveling the complexity
31 Oct 2017Powerful
new technologies shed light on the origin and maturation process of key immune
system cells
Flu vaccine enables rapid response
8 Apr 2014A more efficient production process for influenza vaccines could help to cope with future pandemics
Getting personal with hep B vaccines
17 Dec 2013Manipulating a population of blood cells in an individual could help to activate immune responses against the hepatitis B virus
Personalized vaccines edge closer
10 Sep 2013A technique for analyzing specific T-cell responses could pave the way for more rationally designed vaccines
One step closer to Singapore’s first influenza vaccine
16 Jul 2013A*STAR’s new vaccine, based on a virus-like particle technology created by Cytos Biotechnology AG, could strengthen Singapore’s ability to tackle influenza pandemics
Vaccine hope for virile virus
3 Jul 2012Exploiting the early immune response in Chikungunya fever promises to provide protection
Spotting the invaders
8 Nov 2011A vaccine against a devastating form of malaria common in Asia and South America is one step closer thanks to a long-awaited methodological advance
A sign of things to come
22 Jun 2010Genomic technologies developed by A*STAR’s Singapore Immunology Network (SIgN) form the basis for a new vaccine development platform that could pave the way for cost-effective personalized therapy